Cargando…

New developments in the treatment of rosacea – role of once-daily ivermectin cream

Rosacea is a chronic dermatological disorder with a variety of clinical manifestations localized largely to the central face. The unclear etiology of rosacea fosters therapeutic difficulty; however, subtle clinical improvement with pharmacologic treatments of various drug categories suggests a multi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cardwell, Leah A, Alinia, Hossein, Moradi Tuchayi, Sara, Feldman, Steven R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4807898/ https://www.ncbi.nlm.nih.gov/pubmed/27051311 http://dx.doi.org/10.2147/CCID.S98091

Ejemplares similares

Cost-Effectiveness of Ivermectin 1% Cream in Adults with Papulopustular Rosacea in the United States
por: Taieb, Alain, et al.
Publicado: (2016)

Spotlight on brimonidine topical gel 0.33% for facial erythema of rosacea: safety, efficacy, and patient acceptability
por: Anderson, Michael S, et al.
Publicado: (2017)

Papulopustular Rosacea Treated With Ivermectin 1% Cream: Remission of the Demodex Mite Infestation Over Time and Evaluation of Clinical Relapses
por: Trave, Ilaria, et al.
Publicado: (2022)

Treatment of ocular Demodex infestation with topical ivermectin cream
por: Helm, Craig J.
Publicado: (2022)

New indications for topical ivermectin 1% cream: a case series study
por: Barańska-Rybak, Wioletta, et al.
Publicado: (2019)

Superior Efficacy with Ivermectin 1% Cream Compared to Metronidazole 0.75% Cream Contributes to a Better Quality of Life in Patients with Severe Papulopustular Rosacea: A Subanalysis of the Randomized, Investigator-Blinded ATTRACT Study
por: Schaller, Martin, et al.
Publicado: (2016)

Successful treatment of ivermectin refractory demodicosis with isotretinoin and permethrin cream
por: Paichitrojjana, Anon, et al.
Publicado: (2022)

Interventions to increase adherence to acne treatment
por: Moradi Tuchayi, Sara, et al.
Publicado: (2016)

Long‐term inflammatory rosacea management with subantibiotic dose oral doxycycline 40 mg modified‐release capsules once daily
por: Del Rosso, James Q., et al.
Publicado: (2021)

Once-daily topical treatment for psoriasis: calcipotriene + betamethasone two-compound topical formulation
por: Shepherd, Jonisha, et al.
Publicado: (2013)

Tapinarof Cream 1% Once Daily for the Treatment of Plaque Psoriasis: Case Photography of Clinical Outcomes from Three Phase 3 Trials
por: Desai, Seemal R., et al.
Publicado: (2023)

Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations
por: Ebbelaar, Chiel Cristiano F., et al.
Publicado: (2018)

Once-daily dosing of gentamicin.
por: Soper, D E
Publicado: (1998)

ONCE DAILY RISPERIDONE IN TREATMENT OF SCHIZOPHRENIA
por: Agarwal, Vivek, et al.
Publicado: (2001)

Diet and rosacea: the role of dietary change in the management of rosacea
por: Weiss, Emma, et al.
Publicado: (2017)

A Randomized Controlled Pilot Study: Combined 595‐nm Pulsed Dye Laser Treatment and Oxymetazoline Hydrochloride Topical Cream Superior to Oxymetazoline Hydrochloride Cream for Erythematotelangiectatic Rosacea
por: Sodha, Pooja, et al.
Publicado: (2021)

Comparison of Once-Daily Bromfenac 0.07% Versus Once-Daily Nepafenac 0.3% in Patients Undergoing Phacoemulsification
por: Toyos, Melissa M.
Publicado: (2019)

Role of once-daily glycopyrronium bromide (NVA237) in the management of COPD
por: D’Urzo, Anthony
Publicado: (2013)

Does Once-Daily Raltegravir Have Any Role in the Antiretroviral Treatment?
por: Gutierrez-Valencia, Alicia, et al.
Publicado: (2015)

The efficacy, safety, and tolerability of ivermectin compared with current topical treatments for the inflammatory lesions of rosacea: a network meta-analysis
por: Siddiqui, Kashif, et al.
Publicado: (2016)

Topical Metronidazole Versus Ivermectin for Low-density Demodex Rosacea: A Rater-blinded, Randomized, Split-face Trial
por: YEH, Marvin Chia-Han, et al.
Publicado: (2022)

Successful treatment of multinucleate cell angiohistiocytoma with fractionated ablative CO(2) laser
por: Moradi Tuchayi, Sara, et al.
Publicado: (2019)

Benefits of once-daily therapies in the treatment of hypertension
por: Flack, John M, et al.
Publicado: (2011)

ONCE DAILY LITHIUM IN THE PROPHYLAXIS OF MOOD DISORDERS
por: Mohan, Rajesh, et al.
Publicado: (1996)

Pharmacodynamic characteristics of lixisenatide once daily versus liraglutide once daily in patients with type 2 diabetes insufficiently controlled on metformin
por: Kapitza, C, et al.
Publicado: (2013)

Facial Demodicosis-Induced Skin Hyperpigmentation in an Immunocompromised Man Treated Successfully with Ivermectin 1% Cream: A Case Report
por: Al Harbi, Sadan Mohammed, et al.
Publicado: (2023)

Maintaining remission in ulcerative colitis – role of once daily extended-release mesalamine
por: Oliveira, Lilliana, et al.
Publicado: (2011)

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine
por: Zandman, Daniel B, et al.
Publicado: (2009)

New observations with CREAM
por: Seo, Eun-Suk
Publicado: (2005)

Is once enough? Understanding the preferences of COPD and asthma patients for once- versus twice-daily treatment
por: Horne, Rob
Publicado: (2013)

A prospective cohort conversion study of twice-daily to once-daily extended-release tacrolimus: role of ethnicity
por: Glick, Lauren, et al.
Publicado: (2014)

Once-daily treatment of ADHD with guanfacine: patient implications
por: Strange, Brandon C
Publicado: (2008)

The use of once-daily dosing of gentamicin in obstetrics and gynecology.
por: Wiesenfeld, H C, et al.
Publicado: (1998)

Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
por: Wentrup, Andreas, et al.
Publicado: (2009)

Once-daily medications for the pharmacological management of ADHD in adults
por: Tcheremissine, Oleg V, et al.
Publicado: (2009)

Potential benefit of dolutegravir once daily: efficacy and safety
por: Fantauzzi, Alessandra, et al.
Publicado: (2013)

Update on once-daily zonisamide monotherapy in partial seizures
por: Afra, Pegah, et al.
Publicado: (2014)

Once– versus twice–daily tacrolimus: are the formulations equivalent?
por: Ciszek, Michał
Publicado: (2013)

A review of glycemic efficacy of liraglutide once daily in achieving glycated hemoglobin targets compared with exenatide twice daily, or sitagliptin once daily in the treatment of type 2 diabetes
por: Alshali, Khalid Z., et al.
Publicado: (2016)

Current Drug Therapies for Rosacea: A Chronic Vascular and Inflammatory Skin Disease
por: Feldman, Steven R., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_tmmv5oil20dp92kdtthq5ri3nt